Delivery Order SPE2DB24D3013-SPE2DB24FFHRM

Award Date 9/9/24
Potential Completion Date 9/10/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,047.18 firm fixed-price delivery order contract is for the supply of PREMPRO 0.3 MG-1.5 MG tablets. The contract has an ultimate completion date of September 30, 2024 and was awarded on September 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.55 Firm Fixed Price Delivery Order is for the supply of PREMPRO 0.3 MG-1.5 MG TABLET medical products, with a period of performance through November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PREMPRO 0.3 MG-1.5 MG TABLET. The award, valued at $1,030.20, is a delivery order with a firm fixed price under contract SPE2DB24FD0V0. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen, through its Corporate Office division, will deliver the pharmaceutical products to the DLA, which supports military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,019.75 firm fixed-price delivery order is for PREMPRO 0.3 MG-1.5 MG tablets and has a completion date of February 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PREMPRO 0.45-1.5 MG TABLET medical products. The firm-fixed-price delivery order, valued at $1,677.90, has an ultimate completion date of November 15, 2021. The contract was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award, valued at $1,487.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of PREMPRO 0.3 MG-1.5 MG TABLET medical products to support military healthcare...
The federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of PREMPRO 0.625-5 MG TABLET medication with a ceiling value of $1,344.20. The contract has a firm fixed price and is set to expire on September 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award with the Defense Logistics Agency (DLA) Troop Support Medical valued at $1,264.00. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREMPRO 0.3 MG-1.5 MG TABLET, a pharmaceutical product, with a completion date of October 18, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,030.20 firm fixed-price delivery order is for the supply of PREMPRO 0.45-1.5 MG TABLET, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a Delivery Order valued at $2,909.68 with a firm fixed price. The contract, awarded to AmerisourceBergen Drug Corp, is for the provision of PREMPRO 0.3 MG-1.5 MG TABLET UU 28S, a pharmaceutical product. The contract has a period of performance through February 12, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFHRM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PREMPRO 0.3 MG-1.5 MG tablets. The $2,293.08 firm-fixed-price delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is scheduled for completion on September 10, 2024. As a key supplier of pharmaceutical and medical products to various federal agencies, Amerisourcebergen leverages its extensive supply chain to deliver essential medications, supplies, and equipment to support the healthcare needs of the U.S. military, veterans, and other federal beneficiaries.

Generated 12/9/24, 1:43 PM